Conclusion:
Extrinsic warming (to 37°C) does not appear to affect adverse event rates for intravenous injections of iopamidol 300 of less than 6 mL/sec but is associated with a significant reduction in extravasation and overall adverse event rates for the more viscous iopamidol 370.
© RSNA, 2011 (Source: Radiology)
MedWorm Sponsor Message: Find the best January Sales in the UK.
View full post on MedWorm: HIPAA